Pair A
A willing donor is suitable medically but may not be an appropriate direct donor for the intended recipient.
In selected living-donor cases, transplantation may be considered despite an ABO blood-group mismatch. This requires specialised assessment and an appropriate centre-specific protocol.
A swap arrangement may be considered when a willing donor is not suitable for their intended recipient but may be suitable for another recipient, subject to applicable requirements.
When a donor is medically suitable and appropriately matched, direct living-donor transplantation remains another possible pathway. Donor safety is fundamental.
The team assesses liver disease, transplant indication and overall fitness for transplantation.
A potential living donor undergoes detailed medical, laboratory and imaging evaluation. Donor safety is paramount because donation provides no medical benefit to the donor.
The team considers blood group, anatomy, graft size, donor liver health and recipient requirements together.
If a specialised pathway is appropriate, the team explains risks, alternatives and applicable approvals before proceeding.
The team evaluates the blood-group mismatch and recipient factors before deciding whether an ABO-incompatible pathway is appropriate.
Selected centres use protocols intended to reduce immunological risk. The exact protocol should be explained by the treating transplant team.
Patients require close monitoring after transplantation for graft function, rejection, infection and other complications.
Present ABO-Incompatible transplantation as a specialised option for selected cases after individual assessment.
The transplant team should explain risks, alternatives and the rationale for the proposed pathway before proceeding.
Medical and transplant-system requirements should be confirmed for each case; do not publish fixed thresholds or protocol details without separate approval.
A willing donor is suitable medically but may not be an appropriate direct donor for the intended recipient.
Another donor-recipient pair may have a complementary compatibility situation.
If permitted and approved, donors may be paired with alternate recipients through an approved pathway.
The exact exchange pathway depends on medical suitability, donor safety and applicable requirements.
Assessment focuses on the liver disease, indication for transplant and overall fitness for transplantation.
The donor undergoes detailed medical, laboratory and imaging evaluation. Donor safety remains fundamental.
Blood group, liver anatomy, graft size, donor liver health and recipient requirements are considered together.
The potential donor’s liver health is reviewed as part of donor suitability and safety.
Graft size and anatomy are assessed in relation to recipient needs and the proposed pathway.
Any specialised pathway proceeds only after the relevant clinical assessment, explanation of risks and alternatives, and applicable approvals.
Discuss the recipient’s liver disease, transplant indication and potential donor situation.
Assess disease severity and overall fitness for transplantation.
Assess the potential donor’s health, anatomy and suitability, with donor safety as a central requirement.
Review blood group, graft size, anatomy and the available transplant pathway.
If appropriate, the team explains the proposed ABO-incompatible or swap pathway, risks, alternatives and approvals.
After transplantation, patients require close monitoring for graft function, rejection, infection and other complications.
Close post-transplant monitoring includes assessment of graft function.
Patients require monitoring for rejection and other transplant-related complications.
Post-transplant care includes monitoring for infection.
The exact monitoring and management plan is determined by the treating transplant team.
A potential living donor may not be directly compatible with the intended recipient by blood group.
A willing donor may be medically suitable but not an appropriate direct donor for the intended recipient.
Another donor-recipient pair may have a compatible exchange opportunity.
The pathway is considered only after individual medical, compatibility and transplant-system assessment.
Assessment of transplant indication and recipient fitness.
Detailed donor assessment with donor safety as a fundamental requirement.
Blood-group, anatomy and graft-size considerations are reviewed.
MBBS · DNB (General Surgery) · Fellowship in Liver Transplantation, Global Hospital, Chennai
Dr. Manoj Shrivastav is a liver transplant surgeon at Ruby Hall Clinic, Pune, and currently leads the multi-organ transplant programme. He has personally completed over 200 liver transplants in Pune, 100 of them in the past year alone, with a survival rate above 95% and a one-year survival rate of 92% across his transplant series.
He is equipped to handle acute surgical emergencies and trauma across a variety of scenarios, has performed major liver resections for hepatocellular carcinoma and cholangiocarcinoma, and believes a successful transplant depends on excellent teamwork across the entire clinical team — not one surgeon alone.
Meet the TeamIn selected living-donor cases, it may be considered by centres using specialised protocols. Suitability is individual.
A swap or paired-donation arrangement involves donor-recipient pairs whose donors may be matched with alternate recipients, subject to applicable requirements.
No. It may affect the available pathway, but the specific donor-recipient combination must be assessed.
It may be considered in selected living-donor cases after specialist assessment of the recipient, donor, compatibility and proposed pathway.
The pathway includes detailed medical, laboratory and imaging evaluation, together with assessment of donor suitability and safety.
Living donation provides no medical benefit to the donor, so donor safety is a fundamental requirement of the evaluation.
It is a pathway in which donor-recipient pairs that are not suitable for direct transplantation may be considered as part of a compatible exchange, subject to applicable requirements.
No. It is a specialised option for selected cases and requires individual assessment.
The transplant team considers recipient suitability, donor safety, blood group, anatomy, graft size and applicable transplant-system requirements.
Patients require close monitoring for graft function, rejection, infection and other complications.
Speak with the transplant team about donor compatibility, evaluation and the appropriate pathway.